Elevance Health, Inc.

MARSHALL WACE, LLP ELV

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/13/2025

Shares

35,857

Value ($000)

11,586

Weight

0.0%

2019 Q4 - 2025 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/13/2025	11,586	0.0%	35,857	9/30/2025
2024 Q2	8/14/2024	35,763	0.1%	66,000	6/30/2024
2023 Q4	2/14/2024	61,059	0.1%	129,483	12/31/2023
2023 Q3	11/14/2023	198,043	0.4%	454,833	9/30/2023
2023 Q2	8/14/2023	236,849	0.5%	533,095	6/30/2023
2023 Q1	5/15/2023	250,902	0.6%	545,665	3/31/2023
2022 Q4	2/14/2023	188,080	0.5%	366,649	12/31/2022
2021 Q4	2/14/2022	225,676	0.5%	486,857	12/31/2021
2021 Q3	11/15/2021	22,931	0.1%	61,506	9/30/2021
2021 Q2	8/13/2021	25,830	0.1%	67,652	6/30/2021
2021 Q1	5/17/2021	68,574	0.4%	191,037	3/31/2021
2020 Q4	2/16/2021	76,321	0.5%	237,692	12/31/2020
2020 Q3	11/16/2020	47,061	0.3%	175,214	9/30/2020
2020 Q2	8/13/2020	14,716	0.1%	55,959	6/30/2020
2020 Q1	5/15/2020	19,132	0.2%	84,271	3/31/2020
2019 Q4	2/14/2020	43,329	0.3%	143,459	12/31/2019